In a strategic move to bolster its leadership in metabolic research and clinical care, NYU Langone Health has named Marcus…
The Molecular Discovery: A New Frontier in Preventive Cardiology The research focuses on subclinical carotid atherosclerosis (SCA), a condition characterized…
The clinical narrative surrounding semaglutide, the blockbuster glucagon-like peptide-1 (GLP-1) receptor agonist, is undergoing a profound transformation. Long shadowed by…
The clinical management of obesity has reached a critical juncture as healthcare providers and professional organizations seek to bridge the…
The observance of American Heart Month in February serves as a critical juncture for the medical community to evaluate the…
The United States Congress has finalized a comprehensive funding bill for the Department of Health and Human Services (HHS) for…
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed to manage type 2 diabetes, have undergone a rapid evolution in clinical…
The landscape of metabolic medicine has undergone a seismic shift with the introduction and rapid adoption of glucagon-like peptide-1 receptor…
The Endocrine Society has unveiled a comprehensive strategic framework designed to fortify the global endocrine research community, centering its efforts…
The Endocrine Society has officially announced that Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science…
Amara Maple